ATE37372T1 - Spiro-imidazolone fuer die behandlung von diabetischen komplikationen. - Google Patents

Spiro-imidazolone fuer die behandlung von diabetischen komplikationen.

Info

Publication number
ATE37372T1
ATE37372T1 AT85305115T AT85305115T ATE37372T1 AT E37372 T1 ATE37372 T1 AT E37372T1 AT 85305115 T AT85305115 T AT 85305115T AT 85305115 T AT85305115 T AT 85305115T AT E37372 T1 ATE37372 T1 AT E37372T1
Authority
AT
Austria
Prior art keywords
pct
spiro
treatment
diabetic complications
imidazolone
Prior art date
Application number
AT85305115T
Other languages
English (en)
Inventor
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE37372T1 publication Critical patent/ATE37372T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT85305115T 1984-07-20 1985-07-18 Spiro-imidazolone fuer die behandlung von diabetischen komplikationen. ATE37372T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1984/001155 WO1986000807A1 (en) 1984-07-20 1984-07-20 Spiro-imidazolones for treatment of diabetes complications
EP85305115A EP0171213B1 (de) 1984-07-20 1985-07-18 Spiro-imidazolone für die Behandlung von diabetischen Komplikationen

Publications (1)

Publication Number Publication Date
ATE37372T1 true ATE37372T1 (de) 1988-10-15

Family

ID=22182207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85305115T ATE37372T1 (de) 1984-07-20 1985-07-18 Spiro-imidazolone fuer die behandlung von diabetischen komplikationen.

Country Status (19)

Country Link
US (1) US4680306A (de)
EP (1) EP0171213B1 (de)
KR (1) KR870000626B1 (de)
AT (1) ATE37372T1 (de)
AU (1) AU553719B2 (de)
CA (1) CA1246085A (de)
DE (1) DE3565106D1 (de)
DK (1) DK329485A (de)
EG (1) EG17281A (de)
ES (1) ES8604594A1 (de)
FI (1) FI80037C (de)
GR (1) GR851763B (de)
HU (1) HU198212B (de)
IL (1) IL75801A (de)
PH (1) PH21886A (de)
PL (1) PL145598B1 (de)
PT (1) PT80829B (de)
WO (1) WO1986000807A1 (de)
ZA (1) ZA855460B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3501B1 (ar) * 2014-12-22 2020-07-05 Servier Lab مشتقات 5-{(بيبرازين - 1-يل)-3-أوكسو - بروبيل}- إيميدازوليدين-2، 4 - دايون كمثبطات ل adamts لمعالجة هشاشة العظام)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985888A (en) * 1969-07-24 1976-10-12 Richardson-Merrell Inc. Methods of inducing sedation using certain spiroalkanone-imides
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
US4147797A (en) * 1978-08-11 1979-04-03 Pfizer Inc. Spiro-furanohydantoin derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives
ATE11781T1 (de) * 1981-05-13 1985-02-15 Imperial Chemical Industries Plc Pharmazeutische zubereitungen, die spirosuccinimidderivate enthalten.
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use

Also Published As

Publication number Publication date
AU4518985A (en) 1986-01-23
ZA855460B (en) 1987-02-25
EG17281A (en) 1989-06-30
FI861125A0 (fi) 1986-03-18
HUT39087A (en) 1986-08-28
IL75801A (en) 1988-09-30
PL145598B1 (en) 1988-10-31
ES545353A0 (es) 1986-02-01
PL254593A1 (en) 1986-06-17
GR851763B (de) 1985-11-26
HU198212B (en) 1989-08-28
DE3565106D1 (en) 1988-10-27
WO1986000807A1 (en) 1986-02-13
EP0171213A1 (de) 1986-02-12
KR870000626B1 (ko) 1987-03-26
PH21886A (en) 1988-03-25
PT80829A (en) 1985-08-01
PT80829B (pt) 1987-11-30
EP0171213B1 (de) 1988-09-21
KR860001114A (ko) 1986-02-22
US4680306A (en) 1987-07-14
FI80037C (fi) 1990-04-10
DK329485D0 (da) 1985-07-19
FI80037B (fi) 1989-12-29
FI861125A (fi) 1986-03-18
IL75801A0 (en) 1985-11-29
CA1246085A (en) 1988-12-06
ES8604594A1 (es) 1986-02-01
DK329485A (da) 1986-01-21
AU553719B2 (en) 1986-07-24

Similar Documents

Publication Publication Date Title
DE59407237D1 (de) Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
DK15589A (da) Kemiske forbindelser
SE7906949L (sv) Nya spiro-oxazolidindioner
DE69530933D1 (de) Verwendung von 5-(tetradecyloxy)-2-furan carbonsäure für die behandlung von alzheimer krankheit oder psychosis
DK0790824T3 (da) 2,2-dichloralkancarboxylsyrer, fremgangsmåde til fremstilling deraf, lægemidler indeholdende disse og anvendelse af disse lægemidler til behandling af insulinresistens
DE69413829T2 (de) Antiglucocorticoidsteroide zur behandlung von angststörungen
DE3854121T2 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE69221725D1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
ATE37372T1 (de) Spiro-imidazolone fuer die behandlung von diabetischen komplikationen.
IE832854L (en) Spiro-3-hetero-azolones for treatment of diabetic¹complications.
ATE30585T1 (de) Spirosuccinimide und ihre anwendung in der behandlung von zuckerkrankheitskomplikationen.
NO870423L (no) 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter.
ATE200732T1 (de) Transdermale darreichungsform von nitroglycerin zur verhinderung unerwünschter wehentätigkeit